The 2022 edition of CERA’s Annual Review opens a window to the future showing how research leads to new treatments.

Learn about the innovative research we undertook in 2022, ranging from the future of gene therapy to how we’re improving access to clinical trials.

You’ll also meet some of the people benefiting from new treatments and discover why our research is so important to them.

The theme of CERA’s 2021 Annual Review is Lighting the way. This year we’re highlighting some of the incredible people leading us on our mission to develop better treatments and faster diagnosis of eye disease.

Read about our research into the emerging field of gene therapies, new ways to identify people at risk of developing age-related macular degeneration, and how artificial intelligence can be used to spot disease with just an image of the retina. You’ll also meet the people who support our work, including philanthropic donors and clinical trail participants.

CERA’s 2020 Annual Review explores how our team continued advancing eye research despite the enormous challenges of a global pandemic.

Learn about how our team adapted to keep important research and clinical trials on track.  Read about the results of our world-first clinical into the role of vitamin B3 in glaucoma, a pre-clinical study using gene therapy to regenerate the optic nerve and major funding to use artificial intelligence to screen for blinding eye conditions and cardiovascular disease.

The theme of our 2019 Annual Review is Hope in sight. This reflects our optimism that despite the traumatic events of 2020 – the catastrophic Australian bushfires and the COVID-19 pandemic – our research can make life better for people experiencing vision loss and blindness.

Inside, you’ll learn about some of the advances our researchers are making – from gene and cell therapies, to artificial intelligence tools and beyond. And how the support of individual donors, philanthropic trusts and foundations allows our scientists to conduct vision research with real-life impact.